C0139 Reversal of rivaroxaban-induced prolongation of clotting time with prothrombin complex concentrate (PCC), activated prothrombin complex concentrate (aPCC) and recombinant Factor VIIa (rFVIIa) in vitro

• Elizabeth Perzborn, Stefan Heitmeier, Volker Laux

• Thrombosis Research, October 2012, Elsevier
• DOI: 10.1016/j.thromres.2012.08.037